CN210665509U - Novel depression diagnosis device - Google Patents
Novel depression diagnosis device Download PDFInfo
- Publication number
- CN210665509U CN210665509U CN201920966063.0U CN201920966063U CN210665509U CN 210665509 U CN210665509 U CN 210665509U CN 201920966063 U CN201920966063 U CN 201920966063U CN 210665509 U CN210665509 U CN 210665509U
- Authority
- CN
- China
- Prior art keywords
- diagnosis
- layer
- test paper
- groove
- cellulose nitrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000003745 diagnosis Methods 0.000 title claims abstract description 76
- 208000020401 Depressive disease Diseases 0.000 title claims abstract description 16
- 239000010410 layer Substances 0.000 claims abstract description 56
- 239000007788 liquid Substances 0.000 claims abstract description 56
- 238000012360 testing method Methods 0.000 claims abstract description 51
- 239000000020 Nitrocellulose Substances 0.000 claims abstract description 33
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 claims abstract description 33
- 238000004458 analytical method Methods 0.000 claims abstract description 33
- 229920001220 nitrocellulos Polymers 0.000 claims abstract description 33
- 238000002347 injection Methods 0.000 claims abstract description 23
- 239000007924 injection Substances 0.000 claims abstract description 23
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 16
- 239000011241 protective layer Substances 0.000 claims abstract description 5
- 238000013461 design Methods 0.000 abstract description 3
- 210000002700 urine Anatomy 0.000 description 16
- 238000000034 method Methods 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000009471 action Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 150000003943 catecholamines Chemical class 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 206010012374 Depressed mood Diseases 0.000 description 1
- 238000009007 Diagnostic Kit Methods 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 208000024732 dysthymic disease Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The utility model discloses a novel depression diagnosis device, which comprises a diagnosis box and a transparent cover body connected with the diagnosis box, wherein the transparent cover body is used for being matched and covered on the diagnosis box; the top of the diagnosis box is correspondingly provided with a diagnosis groove and a liquid injection groove, a channel is arranged between the liquid injection groove and the diagnosis groove, a liquid inlet of the channel is connected with the bottom of the liquid injection groove, a liquid outlet of the channel is connected with the diagnosis groove, and the liquid outlet is positioned at the bottom of the side surface of the diagnosis groove; the diagnosis groove is internally provided with test paper, the test paper comprises a first layer of cellulose nitrate analysis test paper, and the top of the first layer of cellulose nitrate analysis test paper is symmetrically provided with a second layer of cellulose nitrate analysis test paper and a color developing agent layer; a transparent film protective layer is arranged on the tops of the second layer of cellulose nitrate analysis test paper and the color developing agent layer; the thickness of the first layer of cellulose nitrate analysis test paper is 0.5-2cm larger than the diameter of the liquid outlet. The utility model discloses simple structure, reasonable in design, convenient to use, the practicality is strong, satisfies medical personnel's diagnosis work's needs.
Description
Technical Field
The utility model relates to a diagnosis device especially relates to a novel depression diagnosis device.
Background
Depression is also called as depressive disorder, is mainly characterized by significant and persistent mood depression, is accompanied by mental diseases such as listlessness, anorexia, sleep disorder and the like which seriously harm human health, and causes great harm to human physical and mental health. At least 3.4 billion depression patients are currently classified as the first major mental illness worldwide. At present, clinical depression diagnosis mainly depends on questionnaire survey for subjective judgment, and the method has long diagnosis period, difficult diagnosis and delayed disease condition. In addition, the detection can be carried out through blood, but the operation is troublesome, a kit is needed, and a complex analysis instrument is needed, so that the method is not suitable for large-scale popularization and application. Compared with blood, the urine is simple, convenient and safe to sample, and is an ideal biological body fluid for detecting the depression. Catecholamine substances are remarkably increased in urine of depression patients and can be used as metabolic markers for depression diagnosis. However, the diagnostic device for urine is less, inconvenient to use and not beneficial to storage, and the requirement of the medical staff for diagnosis work cannot be met.
Therefore, how to overcome the above technical problems becomes a technical problem to be solved urgently by those skilled in the art.
SUMMERY OF THE UTILITY MODEL
The utility model aims at providing a novel depression diagnosis device which can completely solve the defects of the prior art.
The purpose of the utility model is realized through the following technical scheme:
a novel depression diagnosis device comprises a cuboid diagnosis box and a transparent cover body connected with the diagnosis box, wherein the transparent cover body is used for being matched and covered on the diagnosis box; the top of the diagnosis box is correspondingly provided with a diagnosis groove and a liquid injection groove, a channel is arranged between the liquid injection groove and the diagnosis groove, a liquid inlet of the channel is connected with the bottom of the liquid injection groove, a liquid outlet of the channel is connected with the diagnosis groove, and the liquid outlet is positioned at the bottom of the side surface of the diagnosis groove; the diagnosis tank is internally provided with test paper, the test paper comprises a first layer of cellulose nitrate analysis test paper, and a second layer of cellulose nitrate analysis test paper and a color developing agent layer are symmetrically arranged at the top of the first layer of cellulose nitrate analysis test paper; a transparent film protective layer is arranged on the second layer of cellulose nitrate analysis test paper and the top of the color developing agent layer; the thickness of the first layer of cellulose nitrate analysis test paper is 0.5-2cm larger than the diameter of the liquid outlet.
Further, the liquid injection groove is of a cylindrical structure or a conical structure, and a liquid position marking line is arranged in the liquid injection groove.
Further, a sponge is arranged in the channel.
Further, a label card is arranged on the top of the diagnosis box.
Furthermore, a boundary marking line is arranged at the junction of the transparent film protection layer corresponding to the second layer of cellulose nitrate analysis test paper and the color developing agent layer.
Furthermore, the side surface of the port of the diagnosis box buckling transparent cover body is provided with a buckling convex strip.
Compared with the prior art, the beneficial effects of the utility model reside in that: simple structure, reasonable in design, convenient to use, the practicality is strong, can carry out effective diagnosis to the dysthymia patient, satisfies medical personnel's diagnosis work's needs.
Drawings
Fig. 1 is a schematic structural diagram of the present invention;
FIG. 2 is a perspective view of the diagnostic cartridge;
FIG. 3 is a schematic view of the structure of a test paper;
3 FIG. 3 4 3 is 3 a 3 cross 3- 3 sectional 3 view 3 A 3- 3 A 3 of 3 FIG. 3 1 3; 3
Fig. 5 is a schematic structural view of the diagnostic cassette.
Reference numerals: the diagnosis kit comprises a diagnosis box 1, a transparent cover body 2, buckling convex strips 3, a liquid injection groove 4, a diagnosis groove 5, a label card 6, a channel 7, a liquid inlet 8, a liquid outlet 9, test paper 10, a first layer of cellulose nitrate analysis test paper 11, a second layer of cellulose nitrate analysis test paper 12, a color developing agent layer 13, a transparent film protection layer 14, a boundary marking line 15, a high-level liquid position marking line 16, a low-level liquid position marking line 17 and sponge 18.
Detailed Description
The invention will be further described with reference to the following specific embodiments and the accompanying drawings.
As shown in fig. 1 to 5, a novel depression diagnosis device comprises a cuboid diagnosis box 1 and a transparent cover body 2 connected with the diagnosis box 1, wherein the transparent cover body 2 is used for being matched and covered on the diagnosis box 1. The side surface of the port of the transparent cover body 2 buckled with the diagnosis box 1 is provided with a buckling convex strip 3, which is beneficial to the stable buckling of the transparent cover body 2 on the diagnosis box 1 and can not be automatically opened under the action of no external force. The top of the diagnosis box 1 is provided with a liquid injection groove 4, a diagnosis groove 5 and a label card 6 from left to right in sequence, the liquid injection groove 4 is used for injecting urine, the diagnosis groove 5 is used for diagnosing, and the label card 6 is used for marking corresponding diagnosis information (such as the name, sex, age and diagnosis result of a diagnosed person, the name of a diagnosis medical care worker, etc.). A channel 7 is arranged between the liquid injection groove 4 and the diagnosis groove 5, a liquid inlet 8 of the channel 7 is communicated with the liquid injection groove 4 from the bottom of the liquid injection groove 4, a liquid outlet 9 of the channel 7 is communicated with the diagnosis groove 5 from the side surface of the diagnosis groove 5, and the liquid outlet 9 is positioned at the bottom of the side surface of the diagnosis groove 5 and is tangent to the bottom of the diagnosis groove 5. Be provided with test paper 10 in diagnosing the groove 5, test paper 10 includes first layer cellulose nitrate analysis test paper 11, and 11 tops symmetries of first layer cellulose nitrate analysis test paper are provided with second layer cellulose nitrate analysis test paper 12 and colour development agent layer 13. A transparent film protection layer 14 is arranged on the top of the second layer of nitrocellulose analysis test paper 12 and the color developing agent layer 13. The thickness of the first layer of nitrocellulose analysis strip 11 is 0.5-2cm greater than the diameter of the outlet 9, and the purpose is that urine flowing from the outlet 9 is soaked upwards from the first layer of nitrocellulose analysis strip 11 to the second layer of nitrocellulose analysis strip 12 and the developer layer 13 by capillary action. The second layer of nitrocellulose assay paper 12 and the developer layer 13 are of equal thickness. The developer layer 13 is a nitrocellulose analysis paper mixed with a developer, and the first layer 11 and the second layer 12 are paper not mixed with a developer. The transparent film protective layer 14 is provided with a demarcation marking 15 corresponding to the juncture of the second layer of nitrocellulose analysis test paper 12 and the color developing agent layer 13, which is beneficial to dividing the two areas. The first letter "D" is the pinyin letter "pair" and means the meaning of the control, on the top of the diagnostic cartridge 1 corresponding to the area of the second layer of nitrocellulose analysis strip 12. The letter "C" which is the initial of pinyin for "test" is provided on the top of the diagnostic kit 1 corresponding to the area of the developer layer 13, meaning the test. Thus, the medical staff can clearly identify the area.
In the testing process, in order to ensure that a proper amount of urine is added, the amount of urine is not too much or too little, the liquid injection groove 4 is set to be of a cylindrical structure or a conical structure, and a liquid position marking line is arranged in the liquid injection groove 4. The liquid position marked line is divided into a high-position liquid position marked line 16 and a low-position liquid position marked line 17, the liquid poured into the liquid injection groove 4 is positioned between the high-position liquid position marked line 16 and the low-position liquid position marked line 17, and then the urine is waited to be slowly diffused and soaked in the test paper 10.
Since the test is conducted through the passage 7 to gradually penetrate the test paper 10, the passage 7 cannot be set small, for example, 2 to 5mm in diameter. In order to prevent foreign matter from falling into the priming reservoir 4 during operation and blocking the channel 7, a sponge 18 is provided in the channel 7. The sponge 18 can be arranged only at the liquid inlet 8 of the channel 7, or the whole channel 7 can be arranged.
The utility model discloses simple structure, reasonable in design, convenient to use, the practicality is strong, can effectively diagnose the depression patient, satisfies medical personnel diagnostic work's needs. The operation process is to collect urine of a patient, preferably the first urine in the morning with empty stomach. Opening the transparent cover body 2 of the diagnosis device, filling corresponding related information on the label card 6, and then quickly pouring urine into the liquid injection groove 4, wherein the liquid level of the urine is positioned between the high-level liquid position marking 16 and the low-level liquid position marking 17. Cover transparent lid 2, place in the shade, the 10-15 minutes of stewing, the urine in notes liquid groove 4 soaks in test paper 10 through passageway 7, and the effect of rethread capillary upwards soaks, reaches second layer cellulose nitrate analysis test paper 12 and colour development agent layer 13. Catecholamines in the urine react with the color-developing agent in the color-developing agent layer 13, for example, the patient with depression turns purple, which is in sharp contrast to the second layer of nitrocellulose analysis paper 12. The test paper of a normal person is light yellow, and the color of the second layer of the nitrocellulose analysis test paper 12 is not greatly different from that of the color developing agent layer 13. After the result is detected, the result is filled in the label card 6, the transparent cover body 2 is covered, the file can be stored, and the patient can be compared with the next test of the patient to better know the disease symptoms.
And (3) clinical trials:
urine of 200 outpatients in psychiatric department of a hospital is randomly collected, and urine of 200 normal persons is randomly collected to form a control group, and the diagnosis test is carried out by the method. Further, 200 clinical staff in psychiatric department were subjected to questionnaire test by a medical professional and compared with the test results of the test apparatus as a judgment standard for comparison, and the results are as follows:
therefore, the device tests the normal people completely correctly without errors. Through questionnaire survey and test comparison on psychiatric patients, the accuracy rate is basically consistent, the sensitivity is high, and the method is suitable for popularization and application. The device does not need professional technical personnel to operate, is very simple, does not need special instruments and equipment, has low cost, has a clear diagnosis result, is suitable for medical personnel, can be used for family use, and actually detects the self health condition.
The above description is only exemplary of the present invention and should not be taken as limiting the scope of the present invention, as any modifications, equivalents, improvements and the like made within the spirit and principles of the present invention are intended to be included within the scope of the present invention.
Claims (6)
1. A novel depression diagnosis device characterized in that: the diagnosis box comprises a cuboid diagnosis box and a transparent cover body connected with the diagnosis box, wherein the transparent cover body is used for being matched and covered on the diagnosis box; the top of the diagnosis box is correspondingly provided with a diagnosis groove and a liquid injection groove, a channel is arranged between the liquid injection groove and the diagnosis groove, a liquid inlet of the channel is connected with the bottom of the liquid injection groove, a liquid outlet of the channel is connected with the diagnosis groove, and the liquid outlet is positioned at the bottom of the side surface of the diagnosis groove; the diagnosis tank is internally provided with test paper, the test paper comprises a first layer of cellulose nitrate analysis test paper, and a second layer of cellulose nitrate analysis test paper and a color developing agent layer are symmetrically arranged at the top of the first layer of cellulose nitrate analysis test paper; a transparent film protective layer is arranged on the second layer of cellulose nitrate analysis test paper and the top of the color developing agent layer; the thickness of the first layer of cellulose nitrate analysis test paper is 0.5-2cm larger than the diameter of the liquid outlet.
2. The novel depression diagnosis device according to claim 1, characterized in that: the liquid injection groove is of a cylindrical structure or a conical structure, and a liquid position marking line is arranged in the liquid injection groove.
3. The novel depression diagnosis device according to claim 1, characterized in that: a sponge is arranged in the channel.
4. The novel depression diagnosis device according to claim 1, characterized in that: and a label card is arranged at the top of the diagnosis box.
5. The novel depression diagnosis device according to claim 1, characterized in that: and a boundary marking line is arranged at the junction of the transparent film protective layer corresponding to the second layer of cellulose nitrate analysis test paper and the color developing agent layer.
6. The novel depression diagnosis device according to claim 1, characterized in that: the side surface of the port of the diagnosis box fastening transparent cover body is provided with a fastening convex strip.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201920966063.0U CN210665509U (en) | 2019-06-25 | 2019-06-25 | Novel depression diagnosis device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201920966063.0U CN210665509U (en) | 2019-06-25 | 2019-06-25 | Novel depression diagnosis device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN210665509U true CN210665509U (en) | 2020-06-02 |
Family
ID=70815487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201920966063.0U Expired - Fee Related CN210665509U (en) | 2019-06-25 | 2019-06-25 | Novel depression diagnosis device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN210665509U (en) |
-
2019
- 2019-06-25 CN CN201920966063.0U patent/CN210665509U/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2194446C2 (en) | Method for following glucose contents in blood | |
| RU2201595C2 (en) | Method for measuring concentration of a substance under study in biological fluid sample | |
| US5443080A (en) | Integrated system for biological fluid constituent analysis | |
| AU2002313476B2 (en) | Device for collecting liquid samples | |
| RU2188425C2 (en) | Device usable in instrument for measuring concentration of substance under study in biological fluid sample | |
| US8474337B2 (en) | Extraction method, extraction vessel for use with the same, extraction kit and valve expansion member | |
| US4658833A (en) | Monitoring of drug levels | |
| CN206229378U (en) | A kind of centrifugal routine urinalysis detection micro-fluidic chip | |
| BRPI0806549B1 (en) | SYSTEM FOR TESTING ABUSE DRUGS AND PROCESS TO DETERMINE THE PRESENCE OR ABSENCE OF AN ABUSE DRUG | |
| CN110361529A (en) | A kind of reagent card, detection method and application | |
| US20150009502A1 (en) | Urine analysis device, method and system | |
| EP3155421B1 (en) | Container for determining of analytes and/or chemico-physical parameters, as well as determining of urinary sediment, in urine; and method of full urine analysis using this container | |
| US6558897B2 (en) | Device for determining a substance contained in a body fluid | |
| CN210665509U (en) | Novel depression diagnosis device | |
| CN1377300A (en) | Multiple analyte assay device with sample integrity monitoring system | |
| WO2001079838A1 (en) | Device for detecting analytes related to sample ph | |
| CN207133195U (en) | Multichannel collaurum/Immunofluorescence test micro-fluidic chip | |
| CN101271105B (en) | Spermatozoon activity fast detecting reagent kit and its preparation and use method | |
| US20050112547A1 (en) | Vaginal infection test system and method | |
| CN207816980U (en) | A kind of faeces sampling tube for detection of conveniently occulting blood | |
| McCarron | The use of toxicology tests in emergency room diagnosis | |
| CN109212183B (en) | One-step fecal hemoglobin rapid detection kit | |
| KR102009116B1 (en) | Test strip | |
| US20200200739A1 (en) | Urine sampling kit and method | |
| CN201203612Y (en) | Kit for rapidly detecting spermatozoa activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20200602 Termination date: 20210625 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |